JPS5583711A - Serum globulin for stabilized immunity - Google Patents

Serum globulin for stabilized immunity

Info

Publication number
JPS5583711A
JPS5583711A JP10512479A JP10512479A JPS5583711A JP S5583711 A JPS5583711 A JP S5583711A JP 10512479 A JP10512479 A JP 10512479A JP 10512479 A JP10512479 A JP 10512479A JP S5583711 A JPS5583711 A JP S5583711A
Authority
JP
Japan
Prior art keywords
immunity
stabilized
serum globulin
globulin
maltose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10512479A
Other languages
English (en)
Other versions
JPH0232261B2 (ja
Inventor
Eru Randoburatsudo Jiyon
Eru Waanaa Uiriamu
Emu Fuerunandesu Piitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25517325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS5583711(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of JPS5583711A publication Critical patent/JPS5583711A/ja
Publication of JPH0232261B2 publication Critical patent/JPH0232261B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP10512479A 1978-12-18 1979-08-20 Serum globulin for stabilized immunity Granted JPS5583711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/970,686 US4186192A (en) 1978-12-18 1978-12-18 Stabilized immune serum globulin

Publications (2)

Publication Number Publication Date
JPS5583711A true JPS5583711A (en) 1980-06-24
JPH0232261B2 JPH0232261B2 (ja) 1990-07-19

Family

ID=25517325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10512479A Granted JPS5583711A (en) 1978-12-18 1979-08-20 Serum globulin for stabilized immunity

Country Status (7)

Country Link
US (1) US4186192A (ja)
EP (1) EP0012156B1 (ja)
JP (1) JPS5583711A (ja)
AT (1) ATE866T1 (ja)
CA (1) CA1117417A (ja)
DE (1) DE2962569D1 (ja)
MX (1) MX6015E (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05208918A (ja) * 1981-08-24 1993-08-20 Cutter Lab Inc 静注可能な免疫グロブリン

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
SE456136B (sv) * 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
JPH03504605A (ja) * 1988-05-27 1991-10-09 セントカー・インコーポレーテツド 抗体産生物の凍結乾燥した配合物
US5221616A (en) * 1988-07-15 1993-06-22 Quidel Corporation Prevention of spontaneous complement activation in mammalian biological fluids
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
JPH04112544U (ja) * 1990-08-31 1992-09-30 三洋電機株式会社 防水型電話機
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
NZ534542A (en) * 2002-02-14 2006-08-31 Chugai Pharmaceutical Co Ltd Antibody-containing solutions in which the formation of degradation products and insoluble particles during storage and freeze/thaw cycles is inhibited by adding a sugar and surfactant respectively
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
AU2010296017C1 (en) 2009-09-17 2013-09-19 Takeda Pharmaceutical Company Limited Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5420124A (en) * 1977-07-14 1979-02-15 Green Cross Corp:The Preparation of gamma-globulin intravenous injection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB550224A (en) * 1940-08-01 1942-12-30 Lederle Lab Inc Improvements in the preservation of dried blood grouping serum
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
US4089944A (en) * 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5420124A (en) * 1977-07-14 1979-02-15 Green Cross Corp:The Preparation of gamma-globulin intravenous injection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05208918A (ja) * 1981-08-24 1993-08-20 Cutter Lab Inc 静注可能な免疫グロブリン

Also Published As

Publication number Publication date
EP0012156B1 (de) 1982-04-21
CA1117417A (en) 1982-02-02
US4186192A (en) 1980-01-29
JPH0232261B2 (ja) 1990-07-19
ATE866T1 (de) 1982-05-15
EP0012156A1 (de) 1980-06-25
DE2962569D1 (en) 1982-06-03
MX6015E (es) 1984-09-24

Similar Documents

Publication Publication Date Title
JPS5583711A (en) Serum globulin for stabilized immunity
JPS5572111A (en) Colloidal aqueous composition and its manufacture
GB2014115A (en) Bottle stopper
JPS5520190A (en) Bottle retainer
DK554084A (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
ES525156A0 (es) "procedimiento de extraccion liquidonliquido del galio contenido en soluciones acuosas basicas"
NZ192265A (en) Bottle stopper with seal
JPS54159448A (en) Semisolid aqueous coating composition
JPS557287A (en) Aryloxypropanol amine
GB2032437B (en) Method for the preparation of an immune globulin solution suitable for intravenous use
AU4247478A (en) Vehicle seating arangement
IL56648A (en) Stabilized azulmic acids,their preparation and their uses
JPS5535193A (en) Speed reducing valve
IL64157A0 (en) Tridecapeptide,its preparation and its use as a hapten,tracer or antibody
DE3267590D1 (en) Insecticide composition, its preparation and its use
Hamilton Late Cenozoic alkaline volcanics of the Level Mountain Range, northwestern British Columbia: geology, petrology and paleomagnetism
NZ222006A (en) Monoclonal antibodies specific to omega-ifn
JPS57212257A (en) Asymmetrical 1:2-chromium complex compound
JPS54122256A (en) Phenylphsphonite and composition stabilized by said composition
JPS5552391A (en) Aqueous lubricant composition and its manufacture
JPS535124A (en) Organoxilicon composition
JPS54114487A (en) Aqueous surfactant composition
IL57838A0 (en) N-cyclohexyl-n-methoxyacetamide,its preparation and its use in the preparation of o-methyl-n-cyclohexyl-2,5-dimethylfuran-3-hydroxamic acid
JPS5390262A (en) Imidazolonecarboxamide derivs.
JPS53141241A (en) N-p-aminobenzyl-n'-p-aminophenylurea and process for its preparation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees